International Market Access Consulting (IMAC), consists of a global team of passionate individuals with decades of industry and consulting experience. Our team provides custom, high-impact, market access strategies and specialized, evidence‑based tools to effectively communicate the value of your product to key stakeholders in the payer landscape. As a specialist market access consulting company with a proven track record of success, we possess a high level of technical and scientific expertise to help our clients achieve their goals of optimized patient access for their products.
Keshalini Sabaratnam
Keshalini has a diverse background with over 12 years in academia, strategic market access consulting, and data analytics. She has significant experience executing complex strategic market access projects for the top 10 pharma companies. Keshalini holds a PhD from the University of Oxford and completed a post-doctoral fellowship at Harvard Medical School.
Keshalini’s expertise spans global market access /HTA strategy, value communication, and health economics. She also has experience and interest in developing digital AI products.